Matching slides 6,044
Current window 2,941-2,970
Pages 202
Rows per page 30
Slide function: Plan Implementationclear collectionreset all

Slide function

2,941-2,970 of 6,044

filter-aware
18
Includes specific dosing details and regulatory designations (Orphan Drug, Fast Track).Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations 1 hit
19
The slide uses a timeline-based process flow to illustrate capital allocation strategy.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations 1 hit
22
The slide uses a table format to present a roadmap of clinical milestones.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations 1 hit
19
Credit Suisse | Investor Event Presentation Deck | 43 slidesCredit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
29
The slide combines a summary table of capital raise details with a horizontal timeline of execution steps.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
07
The map highlights specific US regions with markers for current, planned, and target locations.CrossFirst Bankshares | Results Presentation Deck | 28 slides · CrossFirst Bankshares
Conference presentation Investor relations Beat · WhatLoop · Cost Of Inaction1 hit
05
The slide uses a chevron-based timeline to illustrate corporate evolution.CURO Group Holdings | Credit Presentation Deck | 23 slides · CURO
Pitch deck Investor relations 1 hit
20
The slide uses a process flow diagram to explain the operational workflow for loan approvals.CURO Group Holdings | Credit Presentation Deck | 23 slides · CURO
Pitch deck Investor relations 1 hit
22
The slide outlines a transition from branch-based servicing for early-stage delinquencies to centralized servicing for late-stage delinquencies, including the role of Ad Astra.CURO Group Holdings | Credit Presentation Deck | 23 slides · CURO
Pitch deck Investor relations 1 hit
08
The slide uses a horizontal bar chart format to represent clinical trial stages for various assets.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
11
The slide uses a structured grid layout to present seven distinct product development programs.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
15
The slide uses a callout box to summarize the upcoming milestones for the company's pipeline.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
39
The slide uses a grid layout to organize seven distinct product candidates with their respective development status and value propositions.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
48
The slide outlines a development roadmap with specific milestones and associated funding amounts.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
62
The diagram uses a Venn-like or nested circle structure to categorize initiatives.Deezer | Investor Day Presentation Deck | 93 slides · Deezer
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
66
The slide uses a nested circle diagram to represent the progression of initiatives.Deezer | Investor Day Presentation Deck | 93 slides · Deezer
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
08
The slide uses a Gantt-style visualization to show progress of drug candidates.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
18
The slide uses a ribbon-style process diagram to show progression from proof-of-concept to clinical trials.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
23
The slide uses a ribbon-style timeline visualization.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
27
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
33
The slide uses a ribbon-style process diagram to show sequential milestones.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
37
The slide uses a process-oriented layout to categorize projects into 'Therapeutic Vaccine Platform' and 'Platform Expansion'.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Loop · Why Now1 hit
06
Faraday Future | Investor Presentation Deck | 39 slidesFaraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
18
The slide uses a comparison table to contrast self-run vs contract manufacturing.Faraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations Beat · Market Size1 hit
21
The slide outlines a direct sales model combining digital purchase processing with physical brand stores and partner stores.Faraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations 1 hit
33
Uses a hybrid diagram combining a service ecosystem map on the left and a phased implementation table on the right.Faraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style chart to visualize the progress of drug candidates through discovery, preclinical, and clinical phases.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
16
The slide outlines a clinical trial methodology comparing combination therapy against monotherapy continuation.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
17
Clinical trial methodology slide detailing study arms and endpoints.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
22
Clinical trial methodology slide detailing study design and endpoints for two phases.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit